« New Guidelines recommend thrombolysis for Proximal DVT | Main | The Flair Covered Graft from Bard Vascular »
The voluntary withdrawal of the Outback Re-entry device from the vascular device market by Cordis Vascular (Johnson and Johnson) has left a void in the tool box with regards to the treatment of long segment total occlusive lesions of the femoral popliteal segment. I found an interesting article recently reviewing the FDA approved options. click here
Vascular Device Forum welcomes submission on tips about recanalizing CTO lesions.
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed1b9968833010534a9e366970c
Listed below are links to weblogs that reference Chronic Total Occlusion-optoons:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments